<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DAR32 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>DAR32</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dileucine Arginine 32</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.33</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>84221</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000105011</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9Y5Z0</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CLLD8, C17orf91, KLP1</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
DAR32 (Dileucine Arginine 32), also known as CLLD8 or C17orf91, is a gene that encodes a protein involved in intracellular trafficking and sorting pathways. Originally identified in immunological studies, DAR32 has emerged as a protein with significant relevance to neurodegenerative diseases through its roles in endosomal-lysosomal trafficking, protein quality control, and cellular homeostasis[@chen2019].
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DAR32 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>DAR32</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dileucine Arginine 32</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.33</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>84221</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000105011</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9Y5Z0</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CLLD8, C17orf91, KLP1</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
DAR32 (Dileucine Arginine 32), also known as CLLD8 or C17orf91, is a gene that encodes a protein involved in intracellular trafficking and sorting pathways. Originally identified in immunological studies, DAR32 has emerged as a protein with significant relevance to neurodegenerative diseases through its roles in endosomal-lysosomal trafficking, protein quality control, and cellular homeostasis[@chen2019].
The endosomal-lysosomal system is critical for neuronal health, as neurons are post-mitotic cells that must maintain protein homeostasis throughout life. Dysfunction in this system is a hallmark of many neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). DAR32, as a component of the endosomal sorting machinery, may contribute to the pathogenesis of these conditions.
The DAR32 gene spans approximately 15 kb on chromosome 19q13.33. The gene contains multiple exons that undergo alternative splicing to produce various transcript variants. The protein coding sequence is evolutionarily conserved across mammals, reflecting the fundamental nature of its cellular functions.
The DAR32 protein contains several functional domains:
The protein localizes to endosomal membranes, where it functions as part of larger protein complexes involved in cargo sorting.
DAR32 plays a crucial role in the endosomal sorting machinery:
Early Endosome Function:
Through its role in endosomal trafficking, DAR32 contributes to cellular protein quality control:
DAR32 function affects broader cellular homeostasis:
DAR32 is expressed in various tissues with varying levels:
Within the central nervous system, DAR32 is expressed in:
DAR32 may influence Alzheimer's disease pathogenesis through effects on amyloid precursor protein (APP) processing and amyloid-beta (Aβ) metabolism[@kim2020]:
DAR32 may contribute to tau pathology through:
Neuronal function depends on proper endosomal trafficking for synaptic plasticity:
The autophagy-lysosome system is closely linked to endosomal pathways:
In Parkinson's disease, DAR32 may affect alpha-synuclein (α-syn) pathology[@zhang2023]:
DAR32 plays a role in lysosomal function relevant to PD:
The substantia nigra dopaminergic neurons that are lost in PD may be particularly susceptible to DAR32 dysfunction:
DAR32 may play roles in ALS through:
Given the overlapping pathology with ALS:
DAR32 may also be relevant to Huntington's disease through:
DAR32 expression could serve as:
Potential therapeutic strategies include:
Several challenges must be addressed:
Research on DAR32 in neurodegeneration is still emerging:
Key questions remain:
Advancing the field requires:
DAR32 is a trafficking protein involved in endosomal-lysosomal pathways that are critical for neuronal health. Through its roles in protein sorting, cargo trafficking, and cellular homeostasis, DAR32 may contribute to the pathogenesis of multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and ALS.
The endosomal-lysosomal system is increasingly recognized as a central pathway in neurodegeneration, making DAR32 an interesting candidate for further research. Understanding how DAR32 function affects protein quality control, synaptic function, and cellular viability may lead to new therapeutic approaches for these devastating diseases.
DLGAP1 (DLG Associated Protein 1, also referred to as SAPAP1 or DLGAP1) is a scaffold protein concentrated at the postsynaptic density (PSD) of excitatory glutamatergic synapses, where it serves as a molecular bridge between the NMDA receptor complex and the downstream signaling machinery. DLGAP1 contains multiple PDZ domains through which it binds the C-terminal tails of NMDA receptor subunits (GRIN1/GRIN2) and the SH3 domain of the PSD-95 family proteins, forming a tertiary complex that anchors NMDA receptors at the synapse and couples them to intracellular effectors including Ras-GTPase activating proteins, CaMKII, and profilin. Beyond scaffolding, DLGAP1 organizes downstream signaling compartments and regulates synaptic vesicle trafficking in the presynaptic terminal through interactions with the exocyst complex. DLGAP1 expression is activity-dependent, regulated by neuronal activity and synaptic stimulation; chronic NMDA receptor hypofunction or DLGAP1 knockdown in rodent models produces deficits in social behavior, object recognition memory, and hippocampal synaptic plasticity, phenocopying core endophenotypes of autism spectrum disorder and schizophrenia. In Alzheimer's disease, DLGAP1 transcripts are downregulated in prefrontal cortex, and DLGAP1 genetic variants have been associated with disease risk, suggesting that disruption of the postsynaptic signaling scaffold contributes to synapse loss. DLGAP1 also interacts with the mTORC1 pathway, linking synaptic activity to protein translation dynamics critical for memory consolidation. PMID: 29396406 PMID: 28870203 PMID: 33347690 PMID: 30664629 PMID: 9286858